Bristol Ifex Website Promotes Off-Label Indications, FDA Ad Division Says
Executive Summary
Bristol-Myers Squibb's Ifex website promotes ifosfamide for unapproved uses through the use of a searchable database of Ifex study summaries, an FDA ad division letter maintains.